By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Custom nucleic acids developer Integrated DNA Technologies said today that Glycon will distribute its product and service offerings in Australia.

Under the partnership, Glycon, situated in New South Wales, Australia, will distribute and provide technical support for IDT's portfolio of synthetic DNA and RNA oligos, genes, and supporting products. Glycon will provide local sales and customer support to complement IDTs telephone, e-mail, and web chat services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.